What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.03%Below 5Y avg (3.98%)
Annual Rate
HKD 0.00Paid annual
Payout Ratio
183.1%High
Payback Period
9.7 yr
Last Ex-Dividend
Jun 30, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.55BHKD
325.23M · vs all stocks (USD)
Updated Nov 20, 2026
Revenue (TTM)
2.83BCNY
360.28M · vs all stocks (USD)
Updated Nov 20, 2026
Profit Margin
-1.73%
Updated Nov 20, 2026
Beta
0.7820x
vs all stocks
Updated Nov 20, 2026
52-Week Change
-9.38%
vs all stocks
Updated Nov 20, 2026
Market Capitalization
2.55BHKD
325.23M · vs all stocks (USD)
Updated Nov 20, 2026
Enterprise Value
22.98BHKD
2.93B · vs all stocks (USD)
Updated Nov 20, 2026
Forward P/E
4.54x
Updated Nov 20, 2026
Price to Sales (TTM)
0.9584x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.9×.Updated Nov 20, 2026
Price to Book (MRQ)
0.2289x
Updated Nov 20, 2026
Enterprise to Revenue
8.13x
Updated Nov 20, 2026
Enterprise to EBITDA
11.74x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 11.47×.Updated Nov 20, 2026
Profit Margin
-1.73%
Updated Nov 20, 2026
Operating Margin
30.07%
Updated Nov 20, 2026
Return on Assets (TTM)
1.40%
Updated Nov 20, 2026
Return on Equity (TTM)
-0.10%
Updated Nov 20, 2026
Revenue (TTM)
2.83BCNY
360.28M · vs all stocks (USD)
Updated Nov 20, 2026
Revenue per Share (TTM)
0.3070CNYUpdated Nov 20, 2026
Quarterly Revenue Growth
-10.20%
Updated Nov 20, 2026
Gross Profit (TTM)
1.12BCNY
143.07M · vs all stocks (USD)
Updated Nov 20, 2026
EBITDA (TTM)
2.00BCNY
255.31M · vs all stocks (USD)
Updated Nov 20, 2026
Net Income (TTM)
-48.99MCNY
-6.24M · vs all stocks (USD)
Updated Nov 20, 2026
Quarterly Earnings Growth (YoY)
-64.30%
Updated Nov 20, 2026
Operating Cash Flow (TTM)
3.01BCNY
383.80M · vs all stocks (USD)
Updated Nov 20, 2026
Levered Free Cash Flow (TTM)
-1.53BCNY
-194.41M · vs all stocks (USD)
Updated Nov 20, 2026
Trailing Annual Dividend Rate
0.0030HKDUpdated Nov 20, 2026
Trailing Annual Dividend Yield
1.03%
vs all stocks
Updated Nov 20, 2026
5-Year Average Dividend Yield
3.98%
vs all stocks
Updated Nov 20, 2026
Payout Ratio
183.15%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -30%.Updated Nov 20, 2026
Minority Interest (Equity)
136.29MCNYFY2025 · Dec 31, 2025
Revenue
2.31BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.51BCNYFY2025 · Dec 31, 2025
Gross Profit
802.47MCNYFY2025 · Dec 31, 2025
Operating Income
813.25MCNY
121.95M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
272.21MCNYFY2025 · Dec 31, 2025
Income Tax Expense
115.58MCNYFY2025 · Dec 31, 2025
Net Income
156.63MCNYFY2025 · Dec 31, 2025
EBIT
905.92MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
2.00BCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
283.56MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
12.12MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
633.71MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0178CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0178CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
7.84BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
7.84BSharesFY2025 · Dec 31, 2025
Minority Interests (P&L)
-16.91MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
1.23BCNYFY2025 · Dec 31, 2025
Free Cash Flow
-1.75BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
954.38MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
272.21MCNYFY2025 · Dec 31, 2025
Stock-based Compensation
188.00KCNYFY2025 · Dec 31, 2025
Other Non-cash Items
621.23MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
341.53MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-2.53MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-2.98BCNYFY2025 · Dec 31, 2025
Net Acquisitions
-27.04MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.27BCNYFY2025 · Dec 31, 2025
Sale of Investments
1.26BCNYFY2025 · Dec 31, 2025
Other Investing Activity
164.13MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-2.86BCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
4.64BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-3.81BCNYFY2025 · Dec 31, 2025
Common Stock Repurchase
-42.05MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-251.44MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-104.53MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
437.76MCNYFY2025 · Dec 31, 2025
Shares Outstanding
7.81BSharesUpdated Nov 20, 2026
Float Shares
5.03BSharesUpdated Nov 20, 2026
% Held by Insiders
37.15%
vs all stocks
Updated Nov 20, 2026
% Held by Institutions
4.40%
vs all stocks
Updated Nov 20, 2026
Total Cash (MRQ)
1.93BCNY
246.36M · vs all stocks (USD)
Updated Nov 20, 2026
Total Cash per Share (MRQ)
0.2100CNYUpdated Nov 20, 2026
Total Debt (MRQ)
21.99BCNY
2.80B · vs all stocks (USD)
Updated Nov 20, 2026
Total Debt to Equity (MRQ)
2.15x
Updated Nov 20, 2026
Current Ratio (MRQ)
1.00x
Updated Nov 20, 2026
Book Value per Share (MRQ)
1.29CNYUpdated Nov 20, 2026
Total Assets
33.16BCNY
4.97B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
6.78BCNYFY2025 · Dec 31, 2025
Total Liabilities
24.50BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
26.38BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
17.86BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
6.65BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
919.59MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
20.29MCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.32BCNYFY2025 · Dec 31, 2025
Inventory
19.67MCNYFY2025 · Dec 31, 2025
Accounts Payable
351.91MCNYFY2025 · Dec 31, 2025
Short-term Debt
2.27BCNYFY2025 · Dec 31, 2025
Long-term Debt
16.68BCNYFY2025 · Dec 31, 2025
Common Stock (Book)
67.42MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
8.65BCNY
1.30B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
0.2270HKDUpdated Nov 20, 2026
52-Week High
0.4900HKDUpdated Nov 20, 2026
52-Week Change
-9.38%
vs all stocks
Updated Nov 20, 2026
Beta
0.7820x
vs all stocks
Updated Nov 20, 2026
50-Day MA
0.3179HKDUpdated Nov 20, 2026
200-Day MA
0.3355HKDUpdated Nov 20, 2026
Avg 10-Day Volume
4.16MSharesUpdated Nov 20, 2026
Avg 30-Day Volume
6.27MSharesUpdated Nov 20, 2026
Diluted EPS (TTM)
-0.0100CNYUpdated Nov 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.22: distress zoneCritical
Altman Z-Score: 0.22
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Companies that share the same coordination system — how they create, deliver, or capture value.